Business Context and Reporting Period
This Form 6-K filing by Enlivex Ltd. covers the month of July 2026. The report details the implementation of a reverse share split previously authorized by shareholders on February 3, 2026.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate actions regarding share capital structure.
Material Changes
- Reverse Share Split Ratio: The Board of Directors finalized the ratio at 1-for-15.
- Share Count Reduction: Issued and outstanding ordinary shares will decrease from 252,480,222 to approximately 16,832,015.
- Authorized Shares: Authorized ordinary shares will be reduced from 2,375,000,000 to 158,333,334.
- Par Value Adjustment: The par value per share will increase from NIS 0.40 to NIS 6.00.
- Trading Details: Split-adjusted trading on the Nasdaq Capital Market under the symbol "ENLV" is expected to begin on July 9, 2026.
- Fractional Shares: No fractional shares will be issued; all fractional interests will be rounded up to the nearest whole share.
- Derivatives: A proportionate adjustment will be made to the exercise price and share count for all outstanding warrants and options.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management commentary on future operations, or specific risk factors beyond the mechanics of the reverse split. The company notes that the split does not affect a shareholder's ownership percentage, except for minor adjustments due to the rounding of fractional shares.
Investor Verification Checklist
- Confirm the effective date of the reverse split and the start of split-adjusted trading on July 9, 2026.
- Verify the final number of shares held after the rounding of fractional shares.
- Check the adjusted exercise prices and share quantities for any held options or warrants.
- Review instructions from the transfer agent, VStock Transfer, LLC, regarding the exchange of share certificates.